- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03792399
Continuous Glucose Monitoring With Immediate or Delayed Counseling Feedback
Impact of Innovative Technology on Geriatric Diabetic Patients: Evaluation of Quality of Life, Self Efficacy and Glycemic Control Among Patients With Experience of Continuous Glucose Monitoring
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
After scheduled routine professional continuous glucose monitoring (CGM) exam, participants in both the intervention and control group receive ordinary education and regimen adjustment as indicated based on CGM results. For participants in the intervention group, they will also receive CGM counseling immediately on the day of CGM sensor removal. For participants in the control group, they will receive CGM counseling on the day of routine 3 months outpatient visit.
Qualitative data are collected through in-depth interview: User expectation, acceptability and satisfaction of CGM are also explored during in-depth interview with a semi-structured questionnaire.
Quantitative data were collected through validated questionnaires, including evaluation of depression by a short form of the Center for Epidemiologic Studies Depression Scale Revised (CES-D-R), emotional stress by Problem Areas in Diabetes Scale (PAID), self efficacy by Stanford Self-Efficacy for Diabetes (SES), at pretest and 3 months after CGM counseling.
Anthropometric Measurements. Body height, body weight, body mass index, and blood pressure were recorded at pre-test and post-test interview.
Blood Tests. Routine biochemistry, fasting plasma glucose, hemoglobin A1c (HbA1c) are collected within 2 weeks of pretest and posttest day.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age 45 years old or more at recent outpatient visits;
- Type 2 diabetic patients followed up at National Cheng Kung University Hospital;
- Patients planned to receive CGM suggested by primary care physician due to inadequate controlled blood glucose.
Exclusion Criteria:
- Patients with diagnosis of generalized inflammation, advanced malignancy, end-stage renal disease on regular dialysis, status post renal transplantation, end-stage liver, heart or pulmonary disease;
- Patients who are taking systemic glucocorticoids;
- Any acute or chronic inflammatory disease as determined by a leukocyte count over 10,000/mm3 or clinical signs of infection;
- Patients who could not complete the questionnaires or who could not follow order due to cognitive impairment or in bed-ridden status;
- Patients diagnosed as thalassemia, glucose-6-phosphate dehydrogenase deficiency, and any other hemoglobinopathies that may influence the accuracy of hemoglobulin A1c measurement were also excluded. Patients who received blood transfusion in recent 3 months were also excluded.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Immediate feedback counseling
Professional CGM calibrate blood glucose via a glucsoe-oxidase-impregnated membrane during a 5 day period.
The patient wearing professional CGM is randomized to immediate feedback after data downloaded into computer.
|
Professoinal CGM in combination with diet and exercise record is used as teaching material to help patient realize their blood glucose pattern and to modify their behavior after counseling feedback.
|
|
Autre: Delayed feedback counseling
Professional CGM calibrate blood glucose via a glucsoe-oxidase-impregnated membrane during a 5 day period.
The patient wearing professional CGM is randomized to delayed feedback (standard care, i.e., CGM graphs interpretation at scheduled 3 months outpatient visit).
|
Professoinal CGM in combination with diet and exercise record is used as teaching material to help patient realize their blood glucose pattern and to modify their behavior after counseling feedback.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change of HbA1c
Délai: Baseline and 3 months after CGM counseling
|
Change of HbA1c in 3 months after CGM counseling.
|
Baseline and 3 months after CGM counseling
|
|
Change of score for self efficacy
Délai: Baseline and 3 months after CGM counseling
|
Change of Stanford Self-Efficacy for Diabetes Scale (SES) in 3 months after CGM counseling.
The score for each item ranged from 1-10.
The score of the scale is the mean of the eight items.
Higher number indicated higher self-efficacy.
|
Baseline and 3 months after CGM counseling
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change of score for diabetes associated stress
Délai: Baseline and 3 months after CGM counseling
|
Change of score for Problem Areas in Diabetes Scale (PAID) in 3 months after CGM counseling.
PAID is a 20-item self-reported questionnaire with scale 0-4 for each question, generating a total score of 0-100.
A score of ≥ 40 is defined as emotional burnout.
|
Baseline and 3 months after CGM counseling
|
|
Change of score for depression
Délai: Baseline and 3 months after CGM counseling
|
Change of score for Center for Epidemiologic Studies Depression Scale Revised (CESD-R) in 3 months after CGM counseling.
With 10-ietm CESD-R scale scoring 10 or more defined as having depression (range 0 to 30).
|
Baseline and 3 months after CGM counseling
|
|
Change in diet composition
Délai: Baseline and 3 months after CGM counseling
|
Change of carbohydrate amounts, fruits amount in 3 months after CGM counseling.
|
Baseline and 3 months after CGM counseling
|
|
Change in exercise amount, time spent in light activity
Délai: Baseline and 3 months after CGM counseling
|
Exercise amount recorded by acelerometers, built in sports bracelet (Fitbit Charge HRTM Wireless Heart Rate + Activity Wristband).
Time spent in light activity per day in 3 months after CGM counseling feedback is compared with baseline.
|
Baseline and 3 months after CGM counseling
|
|
Change in exercise amount, time spent in moderate activity
Délai: Baseline and 3 months after CGM counseling
|
Exercise amount recorded by acelerometers, built in sports bracelet (Fitbit Charge HRTM Wireless Heart Rate + Activity Wristband).
Time spent in moderate activity per day in 3 months after CGM counseling feedback is compared with baseline.
|
Baseline and 3 months after CGM counseling
|
|
Change in exercise amount, time spent in intense activity
Délai: Baseline and 3 months after CGM counseling
|
Exercise amount recorded by acelerometers, built in sports bracelet (Fitbit Charge HRTM Wireless Heart Rate + Activity Wristband).
Time spent in intense activity per day in 3 months after CGM counseling feedback is compared with baseline.
|
Baseline and 3 months after CGM counseling
|
|
Change in exercise amount (time spent in sedentary behavior)
Délai: Baseline and 3 months after CGM counseling
|
Exercise amount recorded by acelerometers, built in sports bracelet (Fitbit Charge HRTM Wireless Heart Rate + Activity Wristband).
Time spent in sedentary behavior in 3 months after CGM counseling feedback is compared with baseline.
|
Baseline and 3 months after CGM counseling
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Ching-Ju Chiu, Ph.D., Institute of Gerontology, NCKU
- Chercheur principal: Ye-Fong Du, M.D., NCKUH
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- NCKUH-10508011
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .